Drug shortages due to manufacturing issues prompted the U.K. government to halt parallel exportation of two dozen drugs, starting Friday.
Stockpiling drugs has been a major concern for the country as Brexit approaches. A review by the U.K.’s National Audit Office found that medicines suppliers are less prepared now for a no-deal exit than they were six months ago (see “Timely Access to Medicines Hinges on Logistics in No-Deal Brexit Scenario”).
The list of restricted drugs comprises hormone replacement therapies, adrenaline auto injectors and HBV vaccines.
The restrictions will block wholesalers from purchasing these medicines in the U.K. and reselling them in the E.U., a practice that can “lead to or exacerbate supply shortages in the exporting country,” the department’s CCO, Steve Oldfield, wrote in a letter to wholesalers. The measures also make it illegal to withhold or “hoard” medicines on the list.